1. Home
  2. NVCT vs SBI Comparison

NVCT vs SBI Comparison

Compare NVCT & SBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvectis Pharma Inc.

NVCT

Nuvectis Pharma Inc.

HOLD

Current Price

$8.20

Market Cap

193.4M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Intermediate Muni Fund Inc

SBI

Western Asset Intermediate Muni Fund Inc

HOLD

Current Price

$7.74

Market Cap

109.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVCT
SBI
Founded
2020
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
193.4M
109.7M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
NVCT
SBI
Price
$8.20
$7.74
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$15.33
N/A
AVG Volume (30 Days)
91.7K
39.5K
Earning Date
02-24-2026
01-01-0001
Dividend Yield
N/A
4.52%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.34
$6.96
52 Week High
$11.52
$8.00

Technical Indicators

Market Signals
Indicator
NVCT
SBI
Relative Strength Index (RSI) 63.07 44.80
Support Level $7.22 $7.66
Resistance Level $7.91 $7.87
Average True Range (ATR) 0.44 0.05
MACD 0.02 -0.00
Stochastic Oscillator 69.26 40.00

Price Performance

Historical Comparison
NVCT
SBI

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About SBI Western Asset Intermediate Muni Fund Inc

Western Asset Intermediate Muni Fd Inc is a diversified closed-end management investment company. The fund's objective is to provide a high level of current income exempt from Federal income taxes. Under normal market conditions, the Fund will invest at least 80% of its total assets in municipal obligations. In addition, under normal market conditions, the Fund will invest at least 80% of its total assets in debt securities that are, at the time of investment, rated investment grade by a nationally recognized statistical rating organization or, if unrated, of equivalent quality as determined by the investment manager. The Fund also maintains a dollar-weighted average effective maturity of between three and ten years.

Share on Social Networks: